We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Coronary heart disease
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
Not provided at time of registration
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
2014 Results article in http://www.ncbi.nlm.nih.gov/pubmed/25023641 results
You can take part if:
You may not be able to take part if:
Current information as of 05/03/2010:1. Euroscore <5 2. Emergency operation (immediate revascularisation for haemodynamic instability) 3. Concomitant cardiac procedure with CABG 4. Operation to be carried out via an incision other than a median sternotomy (e.g. anterolateral left thoracotomy) 5. Known contraindication to ONCABG or OPCABG (e.g. calcified aorta, calcified coronaries, small target vessels)
Initial information at time of registration:1. Male patient under 70 years of age with good left ventricular function (ejection fraction greater than 50%)2. Euroscore less than 5 3. Emergency operation (immediate revascularisation for haemodynamic instability)4. Concomitant cardiac procedure with CABG 5. Operation to be carried out via an incision other than a median sternotomy (e.g. anterolateral left thoracotomy)6. Contraindication to ONCABG or OPCABG (e.g. calcified aorta, intramuscular left anterior descending [LAD], calcified coronaries, small target vessels)
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
This information has not yet been provided by the study team. You'll have an opportunity to discuss any risks and benefits that may be associated with this study prior to consenting to taking part.
Prof
David
Taggart
-
david.taggart@orh.nhs.uk
The study is sponsored by University of Oxford (UK) and funded by Medical Research Council (MRC) (UK) (ref: G0700469).
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Or CPMS 4333
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
